Aakaar Medical Technologies IPO GMP: Know Before You Invest
Aakaar Medical Technologies IPO GMP: A Complete Investor Guide
Thinking about investing in the Aakaar Medical Technologies IPO GMP? If yes, this easy-to-understand guide will help you understand everything — from IPO dates and lot sizes to GMP updates, financials, and future prospects.
This SME IPO aims to raise ₹27 crore through a fresh issue of 37.50 lakh shares, with a price band of ₹68 to ₹72 per share. The company, founded in 2013, offers a wide range of aesthetic medical devices catering to dermatologists, plastic surgeons, and cosmetologists. Its product portfolio includes skincare, hair care, laser devices, and medical-grade aesthetic solutions, sourced from countries like South Korea, Spain, and Italy.
📌 What Is the Aakaar Medical Technologies IPO?
Aakaar Medical Technologies Limited is coming out with an SME IPO on the NSE SME platform. The company plans to raise approximately ₹27 crore through a fresh issue of 37.5 lakh shares. This issue follows the book-building method, which is common in IPOs where investors bid within a price range.
Price Band: ₹68–₹72 per share
Lot Size: 1,600 shares per lot
Minimum Investment (Retail): ₹1,15,200 (at the upper end)
Total Issue Size: ₹27 crore
The high minimum investment reflects the SME nature of this IPO, which often involves higher risk but also potentially higher listing gains.
🗓️ Important IPO Dates to Remember
Mark these dates in your calendar if you're planning to apply for this IPO:
So, if you're planning to apply, make sure to place your bid between June 20 and June 24, 2025.
🧪 What Does Aakaar Medical Do?
Founded in 2013, Aakaar Medical Technologies is a healthcare company focused on aesthetic medical devices. It serves a niche but growing market in India, especially targeting:
Dermatologists
Plastic surgeons
Cosmetology and beauty clinics
Their product portfolio includes:
✅ For Skin Care
Home-use kits, fillers, and professional serums
✅ Hair Care
Hair growth serums, oral tablets, and transplant equipment
✅ Aesthetic Dermatology Tools
Tattoo removal lasers, rejuvenation machines, advanced skin treatment devices
✅ Specialty Products
Devices for incontinence and intimate wellness
They don’t manufacture in-house; instead, they import products from Korea, Italy, Spain, and Austria, which helps maintain quality but adds supply chain dependency.
📊 Financial Performance Snapshot (FY 2024 vs. FY 2025)
The company has shown promising growth in recent years. Here’s a quick financial comparison:
Total Assets: ₹34.01 lakh → ₹51.85 lakh
Revenue: ₹46.27 lakh → ₹61.76 lakh
Net Profit: ₹2.87 lakh → ₹6.04 lakh
Net Worth: ₹12.53 lakh → ₹23.20 lakh
Their net profit more than doubled within a year, indicating strong operational performance.
However, it’s important to note that cash flow from operations was negative (–₹540 lakh) due to high inventory buildup. Fortunately, they managed to cover it with a funding inflow of over ₹10 crore, which they plan to utilize for working capital and general corporate purposes.
💹 Aakaar Medical IPO GMP (Grey Market Premium) Today
As of June 17, 2025, the Aakaar Medical IPO GMP is ₹0. That means there’s currently no premium in the unofficial grey market. It indicates that demand is neutral and listing may be close to the issue price (₹72).
📌 What does this mean for you?
GMPs are just indicators — they fluctuate daily and are influenced by investor sentiment. While ₹0 GMP isn’t negative, it suggests you should wait and monitor the trend daily before making a final investment decision.
⚖️ Strengths and Risks
Let’s look at both sides of the coin.
✅ Strengths
Strong leadership with experience in the aesthetics space
Diversified product range (skin, hair, and wellness devices)
Wide distribution network across India through channel partners
Rising revenues and profitability
⚠️ Risks
No manufacturing unit – 100% reliance on foreign suppliers
Currency fluctuations and import costs can impact margins
SME segment volatility – not suitable for extremely risk-averse investors
Limited comparable listed peers, making valuation analysis difficult
🧑💼 Who’s Behind the IPO?
Promoters:
Dilip Ramesh Meswani
Bindi Dilip Meswani
They currently hold 91.11% of the pre-issue equity
Registrar:Bigshare Services Pvt. Ltd.
Lead Manager:Indorient Financial Services Ltd.
These entities will handle the application process, allotment, and investor services.
❓ Frequently Asked Questions (FAQ)
Q1: What is the minimum investment for retail investors?
A: 1 lot = 1,600 shares = ₹1,15,200 at ₹72 per share.
Q2: When is the Aakaar Medical Technologies IPO open for bidding?
A: It opens on June 20 and closes on June 24, 2025.
Q3: What is the price band of the IPO?
A: The price band is ₹68 to ₹72 per equity share.
Q4: What is the listing date of Aakaar Medical IPO?
A: The expected listing date is June 27, 2025.
Q5: What is the current GMP of the IPO?
A: The GMP is ₹0 as of June 17, 2025.
✅ Final Verdict: Should You Apply?
The Aakaar Medical Technologies IPO GMP offers an opportunity to invest in a niche segment of aesthetic medical devices, which is growing steadily in India. The company has shown consistent financial growth, and its diversified product range gives it a competitive edge.
However, the lack of manufacturing capabilities and reliance on imported products makes it vulnerable to global disruptions.
With the current GMP at ₹0, investors should:
Track GMP updates daily
Assess risk appetite
Focus on long-term fundamentals
If you're comfortable with SME IPOs and want exposure to a niche healthcare sector, this IPO might be worth considering.
